Cogniz

Tablet

🧬 Citicoline Sodium 🏢 UniMed UniHealth Pharmaceuticals Ltd.

Generic Name Citicoline Sodium

Manufacturer UniMed UniHealth Pharmaceuticals Ltd.

Unit Price Unit Price: ৳ 50.00 (3 x 10: ৳ 1,500.00) Strip Price: ৳ 500.00

🔹 Indications নির্দেশনা

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Pharmacology ফার্মাকোলজি

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Dosage & Administration

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Interaction মিথস্ক্রিয়া

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Contraindications

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Side Effects

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Pregnancy & Lactation

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Precautions & Warnings সতর্কতা

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

🔹 Pediatric Usage

Information not available in English.

🔹 Storage Conditions সংরক্ষণ

Cogniz is indicated in-

Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months.
Cerebral insufficiency (e.g. dizziness, memory loss, poor concentration & disorientation) due to head trauma or brain injury.
Cognitive dysfunction due to degenerative disease (Alzheimer's disease)
Parkinson's disease: Cogniz has been shown to be effective as co-therapy for Parkinson's disease.

💡 Frequently Asked Questions

Cogniz is indicated in- Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe s...

Cogniz is indicated in- Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe s...

Cogniz is indicated in- Cerebrovascular disease e.g. ischemia due to stroke, where Cogniz accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe s...

User Reviews

⭐

No reviews yet!

Be the first to share your experience.

Write a Review